A case report series study for the effects of Policosanol on Post-Stroke Cognitive Impairment

Ischemic stroke may be a leading explanation for disability, including post-stroke cognitive impairment (CI), that no effective therapy is out there. Post-stroke patients are managed with antiplatelet drugs, and antihypertensive, hypoglycemic and/or cholesterol-lowering drugs, as needed. Policosanol is an antiplatelet and cholesterol lowering agent. Studies done before are demonstrated that adding policosanol to aspirin (AS) therapy improves post-stroke neurological recovery compared to placebo + AS.

Author(s): Javier Sanchez, Trujillo C

Abstract | PDF

Share This Article